fda approval for tirzepatide GROUNDBREAKING UPDATE! has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, weight loss! Previously, has been FDA approved for type 2 diabetes as Mounjaro, and although Yesterday the FDA approved tirzepatide

Establish a skincare routine that supports skin health

*GLP-1 peptides offered by LIVation will come from a US based lab, manufacturer, and/or compounding pharmacy, therefore the product is not FDA approved

doi: 10.7150/ijbs.59965 11

Its best to be cautious with alcohol while taking tirzepatide

They are losing weight visibly and feeling more capable, which (per Morgan Stanleys February 2024 survey of ~300 GLP-1 users) tracks with weekly workout rates jumping from 35% to 77% after starting the drug

HOURS PORTLAND 9am-6pm, Daily LAKE OSWEGO 9am - 5pm, Monday - Friday QUICK LINKS Information on this website is provided for educational and informational purposes only and does not constitute medical advice